Tesa/IPA Spray combines two separate growth-hormone-axis peptides in one spray-dispensed container. Tesamorelin (TH9507) carries the formula C221H366N72O67S, about 5,136 g/mol, CAS 218949-48-5. Ipamorelin carries the formula C38H49N9O5, about 711.9 g/mol, CAS 170851-70-4. The two act through different receptors, Tesamorelin at the GHRH receptor and Ipamorelin at the ghrelin receptor, so each should be identified and verified independently rather than as a single combined entity. Veracue supplies 6 mg of Tesamorelin with 3 mg of Ipamorelin, or 13 mg with 3 mg, strictly for laboratory research use only.
Ask for the analytical documentation of any lot.
HPLC is the method used to measure purity
Ask for the report for a specific lot through the contact page
Supplied for laboratory research use only
Mass spectrometry is the method used to confirm identity
Tesa/IPA Spray is Veracue’s spray-dispensed packaging of two distinct synthetic peptides, Tesamorelin and Ipamorelin, documented together on the Tesa/IPA vial listing. The underlying molecules are identical across both listings; only the packaging and dispensing format differs between them.
"Spray" in this product’s name is a packaging and dispensing descriptor, nothing more. It does not establish a route, a concentration, or a formulation for either peptide, and none of those specifics should be inferred from the name. Chemical form, concentration, ratio, fill volume and storage conditions are reported on each lot’s own documentation and can be requested through the contact page.
| Product name | Tesa/IPA Spray (Tesamorelin + Ipamorelin) |
| Components | Tesamorelin (TH9507) and Ipamorelin (NNC-26-0161) |
| Packaging format | Spray-dispensed, Research Use Only |
| Tesamorelin identity | C221H366N72O67S, about 5,136 g/mol, CAS 218949-48-5 |
| Ipamorelin identity | C38H49N9O5, 711.9 g/mol, CAS 170851-70-4 |
| Sizes offered | 6mg/3mg and 13mg/3mg (tesamorelin mg / ipamorelin mg) |
| Research designation | Research Use Only |
Values above are reference identity data for each molecule, carried over unchanged from the Tesa/IPA vial listing since both listings describe the same two compounds. Purity, chemical form and lot results are reported on each lot’s own documentation and can be requested through the contact page.
Veracue lists Tesa/IPA in more than one packaging format because research groups source and track material differently depending on how it is packaged. Keeping the formats as separate listings keeps lot records, images and documentation specific to the packaging a researcher actually ordered, rather than mixing records across formats.
Tesa/IPA Spray and the Tesa/IPA vial listing describe the same two molecules. Packaging format has no bearing on either peptide’s sequence, formula or mass, so the reference values below are identical across both listings.
| Attribute | Tesamorelin | Ipamorelin |
|---|---|---|
| Molecular class | 44-residue GHRH(1-44) analog with N-terminal hexenoyl group | 5-residue pentapeptide |
| Sequence | Full residue order in the PubChem record (CID 16137828) | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular formula | C221H366N72O67S | C38H49N9O5 |
| Molecular weight | About 5,136 g/mol | About 711.9 g/mol |
| CAS number | 218949-48-5 | 170851-70-4 |
| PubChem CID | 16137828 | 9831659 |
| Receptor studied | GHRH receptor (GHRHR) | Ghrelin / GHS-R1a |
| Synonym | TH9507 | NNC-26-0161 |
| Catalog formats Veracue offers (standalone) | Vial and spray | Vial and spray |
The table compares identity only. It does not rank the two peptides, and neither is a variant of the other. The last row describes each molecule’s own standalone listing, separate from this two-peptide spray listing.
No. The two compounds reported under this listing are the same Tesamorelin and Ipamorelin reported under the vial listing. What differs between the two listings is how the material is packaged and dispensed, not the chemical identity of either peptide.
In Veracue’s catalog, "Spray" is a packaging and dispensing term, comparable to "vial" or "powder" on other listings. It tells a researcher how the product is dispensed from its container. It does not specify a concentration, a ratio between the two peptides, a carrier, or a route, and it is not shorthand for any particular method of use. Those details, where applicable, live in lot-specific documentation rather than in the catalog name.
A two-peptide listing makes this distinction more important, not less: a packaging word says nothing about how much of each peptide a given unit contains relative to the other. A researcher documenting materials in a methods section should cite the lot’s own documentation for format-specific details rather than inferring them from the word "Spray."
Tesamorelin is studied as an agonist at the GHRH receptor (GHRHR), the same receptor family targeted by growth hormone-releasing hormone. Ipamorelin is studied as a selective agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor (GHS-R1a). These are two distinct G protein-coupled receptor systems, so research findings about one peptide do not automatically describe the other.
No. A result obtained with Tesamorelin alone says nothing on its own about the pair, and the same is true for Ipamorelin. The reference material for this listing is molecular identity and receptor-level description for each component, and nothing on this page describes a combined effect between the two.
This page reports molecular reference information and general research context for each peptide, carried over from the vial listing. It cannot establish what a particular spray-format unit contains. Veracue provides no dosing, administration or usage guidance of any kind.
A certificate of analysis documents one lot, never a packaging format or a compound in general. For a two-peptide listing like this one, look for each item below to cover both Tesamorelin and Ipamorelin, because a result for one component says nothing about the other.
| COA item | What it helps establish |
|---|---|
| Lot number | Which production run the results describe. It should match the container and the order record for the spray-format unit received. |
| Identity of Tesamorelin | Whether the measured mass fits the Tesamorelin reference mass of about 5,136 g/mol. |
| Identity of Ipamorelin | Whether the measured mass fits the Ipamorelin reference mass of about 711.9 g/mol. |
| HPLC chromatogram and purity result | How much of the material elutes as each target peak, ideally reported for each peptide. |
| Quantity of each peptide | The milligrams of Tesamorelin and Ipamorelin in the unit, for comparison against the listing name. |
| Test date and laboratory information | Who performed the analysis and how recent it is. |
| Chemical form | Free peptide, acetate or another salt, for each component separately. |
Packaging format has no bearing on which analytical methods apply or on what a complete certificate should contain. A spray-format lot and a vial-format lot of the same two peptides are verified against the same sequence, formula and mass references listed on the Tesa/IPA Spray at a Glance table above. Request lot documentation through the certificate page.
Because this listing holds two peptides, a full identity check has two parts. Tesamorelin should be matched to formula C221H366N72O67S, average mass about 5,136 g/mol, CAS 218949-48-5. Ipamorelin should be matched to formula C38H49N9O5, average mass about 711.9 g/mol, CAS 170851-70-4. A record confirming only one of the two leaves the other unverified, regardless of packaging format.
| Component | Reference mass | Formula |
|---|---|---|
| Tesamorelin | About 5,136 g/mol | C221H366N72O67S |
| Ipamorelin | About 711.9 g/mol | C38H49N9O5 |
A mass spectrometer detects ions, not spray bottles or vials. A peptide can carry one or more charges, so one molecule can show up at several m/z values, and observed signals will not match the molecular weight on a data sheet directly. Adducts and counterions can shift or add signals. The two reference masses here sit far apart, roughly 5,136 against 712, so their signals should not be confused, and interpretation belongs to the analytical record and its stated method conditions.
No. The verification question is the same for either packaging format: does this lot match the stated molecules, and is each purity figure paired with a mass result from that same lot. Packaging format does not change what counts as adequate documentation for a two-peptide listing.
Ask the Veracue team about available documentation for a specific lot, or review the certificate library.
Tesa/IPA Spray is supplied for laboratory research and analytical characterization only. It is not intended for human or veterinary use, or for ingestion, injection or any form of administration. This page contains no dosing, administration or usage guidance of any kind, and the word "Spray" in the product name describes Veracue’s packaging and dispensing format only. See the Medical Disclaimer and the Terms and Conditions for sitewide policies.
RESEARCH PEPTIDE
Spray bottle pairing a 29-residue GHRH analog with the pentapeptide Ipamorelin, 5 mg of each and 45 sprays per bottle. Laboratory research use only.
RESEARCH PEPTIDE
GLP-T Spray pairs a 39-residue peptide, LY3298176 (CAS 2023788-19-2), with a C20 diacid on lysine 20. 10 to 60 mg, research use only, 45 sprays a bottle.
RESEARCH PEPTIDE
A 28-residue, N-acetylated peptide at 3108.3 g/mol, spray-dispensed in a 10 mg bottle with 45 sprays. Supplied for research use only.
RESEARCH PEPTIDE
Seven residues, a lactam ring and an amide terminus: Melanotan II, CAS 121062-08-6, in a 10 mg bottle of 45 sprays. Laboratory research only.
